GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (XBRU:ALIMG) » Definitions » Equity-to-Asset

DMS Imaging (XBRU:ALIMG) Equity-to-Asset : 0.23 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is DMS Imaging Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. DMS Imaging's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €9.89 Mil. DMS Imaging's Total Assets for the quarter that ended in Dec. 2023 was €43.76 Mil. Therefore, DMS Imaging's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.23.

The historical rank and industry rank for DMS Imaging's Equity-to-Asset or its related term are showing as below:

XBRU:ALIMG' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.1   Med: 0.27   Max: 0.85
Current: 0.23

During the past 12 years, the highest Equity to Asset Ratio of DMS Imaging was 0.85. The lowest was -1.10. And the median was 0.27.

XBRU:ALIMG's Equity-to-Asset is ranked worse than
78.61% of 1566 companies
in the Biotechnology industry
Industry Median: 0.66 vs XBRU:ALIMG: 0.23

DMS Imaging Equity-to-Asset Historical Data

The historical data trend for DMS Imaging's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DMS Imaging Equity-to-Asset Chart

DMS Imaging Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.61 -1.10 0.30 0.27 0.23

DMS Imaging Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.31 0.27 0.27 0.23

Competitive Comparison of DMS Imaging's Equity-to-Asset

For the Biotechnology subindustry, DMS Imaging's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DMS Imaging's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DMS Imaging's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where DMS Imaging's Equity-to-Asset falls into.



DMS Imaging Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

DMS Imaging's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=9.892/43.758
=0.23

DMS Imaging's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=9.892/43.758
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DMS Imaging  (XBRU:ALIMG) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


DMS Imaging Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of DMS Imaging's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


DMS Imaging (XBRU:ALIMG) Business Description

Traded in Other Exchanges
Address
7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

DMS Imaging (XBRU:ALIMG) Headlines

No Headlines